During the past decade, Rostov State Medical University conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 41 clinical trials were completed, i.e. on average, 63.1% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 33 clinical trials were completed. i.e. 165% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rostov State Medical University" #1 sponsor was "Celgene" with 8 trials, followed by "Eli Lilly and Company" with 8 trials sponsored, "Takeda" with 6 trials sponsored, "H. Lundbeck A/S" with 5 trials sponsored and "Shire" with 5 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rostov State Medical University" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Cosmo Technologies Ltd" with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator and "Kuban State Medical University" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Rostov State Medical University" are "Ulcerative Colitis" (15 trials), "Crohn's Disease" (8 trials), "Colitis, Ulcerative" (5 trials), "Crohn Disease" (5 trials) and "Diabetes Mellitus" (5 trials). Many other conditions were trialed in "Rostov State Medical University" in a lesser frequency.

Most popular intervention types in "Rostov State Medical University" are "Drug" (70 trials), "Other" (9 trials), "Behavioral" (3 trials), "Biological" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "Mirikizumab" (4 trials), "Ontamalimab" (4 trials), "Ozanimod" (4 trials) and "Vortioxetine" (4 trials). Other intervention names were less common.

The vast majority of trials in "Rostov State Medical University" are 73 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Rostov State Medical University". undefined are not yet recruiting, 13 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Rostov State Medical University, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Rostov State Medical University, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 59 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".